Differences in Prognostic Factors and Outcomes Between Women and Men Undergoing Coronary Artery Stenting
Article Abstract:
Women with coronary artery disease have a similar outcome to men with treated with stents. A stent is a small cylindrical device that is placed inside an artery to keep the artery open. In a study of 1,001 women and 3,263 men who were treated with a stent, 30-day morality rates were higher in women but one-year mortality rates were similar in men and women.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial
Article Abstract:
Giving patients with unstable angina or a heart attack anticoagulant drugs three to five days before angioplasty may not reduce their risk of complications from the procedure, according to a study of 410 patients. Unstable angina and heart attacks are both caused by blood clots that prevent blood flow to the heart. Angioplasty is a procedure used to break up blood clots and other obstructions in the coronary arteries.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: The ISAR-REACT 2 randomized trial
Article Abstract:
A test was conducted to assess whether abciximab is associated with clinical benefit in high risk patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) after pretreatment with 600mg of clopidogrel. Results reveal that abciximab reduces the risk of adverse events in patients with non-ST-segment elevation ACS undergoing PCI after pretreatment with 600 mg of clopidogrel.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE quality improvement initiative
- Abstracts: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial
- Abstracts: Stratified Care vs Step Care Strategies for Migraine: The Disability in Strategies of Care (DISC) Study: A Randomized Trial
- Abstracts: Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema
- Abstracts: The rationale for the current boom in anti-TNFalpha treatment: is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?